Related Experiment Video

Updated: Sep 9, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

[Problems with indications for continuous subcutaneous insulin infusion in 2 juvenile patients with diabetes

G J Bruining, E Van Ballegooie

    Tijdschrift Voor Kindergeneeskunde
    |December 1, 1983
    PubMed

    Insights

    Continuous subcutaneous insulin infusion (CSII) may be risky for children with diabetes experiencing psychosocial issues. This treatment approach showed poor results and potential dangers in minors with complex metabolic disregulation.

    Area of Science:

    • Pediatric Endocrinology
    • Metabolic Disorders
    • Psychosocial Health

    Background:

    • Continuous subcutaneous insulin infusion (CSII) is typically reserved for cases where conventional insulin therapy is insufficient.
    • The interplay between psychosocial factors and chronic metabolic dysregulation in diabetes mellitus is complex.
    • Identifying the primary cause (metabolic issues or psychosocial variables) can be challenging.

    Observation:

    • In pediatric patients with diabetes, metabolic dysregulation can be exacerbated by stress, creating a detrimental cycle.
    • Two pediatric cases involving psychosocial variables and metabolic disregulation were studied.
    • Continuous subcutaneous insulin infusion (CSII) was implemented in these two minors.

    Findings:

    • The application of CSII in these specific pediatric cases yielded unsatisfactory outcomes.
    • The use of CSII in these minors presented potentially dangerous complications.
    • The study highlights the risks associated with CSII in complex pediatric diabetes cases.

    Implications:

    • CSII may not be suitable for all pediatric patients with diabetes, especially those with concurrent psychosocial challenges.
    • Further research is needed to understand the risks and benefits of CSII in vulnerable pediatric populations.
    • Careful consideration of psychosocial factors is crucial when deciding on insulin therapy for children with diabetes.

    More Related Videos

    A Model of Chronic Nutrient Infusion in the Rat08:18

    A Model of Chronic Nutrient Infusion in the Rat

    Published on: August 14, 2013

    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

    Published on: January 4, 2018

    Related Concept Videos

    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

    Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

    Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Insulin Formulations: Types and Delivery01:27

    Insulin Formulations: Types and Delivery

    Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
    Short-acting insulins are divided into rapid-acting...
    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
    Complications of Diabetes Mellitus01:22

    Complications of Diabetes Mellitus

    Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...